CTSO
Cytosorbents Corp
Price:  
1.03 
USD
Volume:  
19,891.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO WACC - Weighted Average Cost of Capital

The WACC of Cytosorbents Corp (CTSO) is 6.9%.

The Cost of Equity of Cytosorbents Corp (CTSO) is 6.95%.
The Cost of Debt of Cytosorbents Corp (CTSO) is 7.00%.

Range Selected
Cost of equity 5.50% - 8.40% 6.95%
Tax rate 3.10% - 4.10% 3.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.6% - 8.3% 6.9%
WACC

CTSO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.35 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 8.40%
Tax rate 3.10% 4.10%
Debt/Equity ratio 0.09 0.09
Cost of debt 7.00% 7.00%
After-tax WACC 5.6% 8.3%
Selected WACC 6.9%